News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | CUDC907 promotes apoptosis of NF2 Schwannoma cells

Oncotarget

July 26, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.” continue reading »

Oncotarget | Predicting cancer immunotherapy response from gut microbiomes using machine learning models

News

July 19, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “Predicting cancer immunotherapy response from gut microbiomes using machine learning models.” continue reading »

Aging | Epigenetic clocks and their association with perceived discrimination and depressive symptoms

Aging

July 18, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 13, entitled, “Epigenetic clocks and their association with trajectories in perceived discrimination and depressive symptoms among US middle-aged and older adults.” continue reading »

Oncotarget | Role of germline variants in the metastasis of breast carcinomas

News

July 7, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on June 30, 2022, entitled, “Role of germline variants in the metastasis of breast carcinomas.” continue reading »

Oncotarget | Continuous Treatment With Abemaciclib Leads to Sustained and Efficient Inhibition of Breast Cancer Cell Proliferation

News

July 6, 2022
PRESS RELEASE: On July 2, a new research paper was published in Oncotarget, entitled, “Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation." continue reading »